Michael H. Mulroy Insider Trading
Get free email notifications about insider trading for Michael H. Mulroy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael H. Mulroy. Michael H. Mulroy is a Director in BIOTIME INC ($BTX) and a EVP, CFO & General Counsel in QUESTCOR PHARMACEUTICALS INC ($QSC) and a See Remarks in QUESTCOR PHARMACEUTICALS INC ($QSC) and a Sr VP, CFO & General Counsel in QUESTCOR PHARMACEUTICALS INC ($QSC) and a President and CEO in Asterias Biotherapeutics, Inc. ($ASTY) and a Director in AgeX Therapeutics, Inc. ($AGE).
Address: 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM 92807 CA
Companies in which Michael H. Mulroy is an Insider
AgeX Therapeutics, Inc.
Trading Symbol: AGEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael H. Mulroy: Director
Holdings: 0 shares
Latest Transaction: Mar 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Asterias Biotherapeutics, Inc.
Trading Symbol: ASTYIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael H. Mulroy: President and CEO
Holdings: 350,210 shares
Latest Transaction: Mar 05 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lineage Cell Therapeutics, Inc.
Trading Symbol: BTXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael H. Mulroy: Director
Holdings: 226,821 shares
Current Value: $694,072
Latest Transaction: Jul 02 2020
$BTX Market Capitalization: $309.34M
$BTX Previous Close: $3.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
QUESTCOR PHARMACEUTICALS INC
Trading Symbol: QSCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael H. Mulroy: See Remarks, EVP, CFO & General Counsel, Sr VP, CFO & General Counsel
Holdings: 75,759 shares
Latest Transaction: Aug 04 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael H. Mulroy
Sentiment: All, AGE, ASTY, BTX, QSC
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 02 2020 | BTX | Lineage Cell Thera ... | Mulroy Michael H. | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
Jul 03 2019 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
Mar 15 2019 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Grant | A | 0.00 | 194,271 | 0 | 226,821 | 32.6 K to 226.8 K (+596.84 %) |
Mar 15 2019 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Grant | A | 0.00 | 194,271 | 0 | 226,821 | 32.6 K to 226.8 K (+596.84 %) |
Mar 13 2019 | AGE | AgeX Therapeutics, ... | Mulroy Michael H. | Director | Option Exercise | A | 4.28 | 65,000 | 278,200 | 65,000 | |
Mar 05 2019 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Payment of Exercise | F | 0.95 | 76,588 | 72,759 | 273,622 | 350.2 K to 273.6 K (-21.87 %) |
Mar 05 2019 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Grant | A | 0.00 | 252,606 | 0 | 350,210 | 97.6 K to 350.2 K (+258.81 %) |